California Public Employees Retirement System’s Vir Biotechnology VIR Stock Holding History

California Public Employees Retirement System’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-133,896	Closed	-$5.61M	–	1258
2021 Q4	$5.61M	Buy	133,896 +12,674	+10%	+$497K	﹤0.01%	1149
2021 Q3	$5.28M	Sell	121,222 -11,334	-9%	-$491K	﹤0.01%	1191
2021 Q2	$6.27M	Sell	132,556 -9,376	-7%	-$426K	﹤0.01%	1181
2021 Q1	$7.28M	Buy	141,932 +23,043	+19%	+$1.24M	0.01%	1238
2020 Q4	$3.18M	Sell	118,889 -2,300	-2%	-$74.8K	﹤0.01%	1701
2020 Q3	$4.16M	Buy	121,189 +27,489	+29%	+$1.18M	﹤0.01%	1358
2020 Q2	$3.84M	Buy	+93,700	New	+$3.14M	﹤0.01%	1358

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

California Public Employees Retirement System's VIR Position: Q1 2022 in Review

California Public Employees Retirement System sold out of Vir Biotechnology (VIR) in Q1 2022, closing a stake of 133,896 shares — an estimated $5.61M sold.

California Public Employees Retirement System first reported a position in VIR in Q2 2020 and held it in 7 quarters. The position peaked at $7.28M in Q1 2021. 204 funds tracked by Wall St. Rank hold VIR as of Q1 2022.

California Public Employees Retirement System reported no remaining Vir Biotechnology position as of Q1 2022 after selling out during the quarter.
California Public Employees Retirement System sold 133,896 Vir Biotechnology shares in Q1 2022, an estimated $5.61M.
California Public Employees Retirement System first reported a position in Vir Biotechnology in Q2 2020 and held it in 7 quarters.
California Public Employees Retirement System's Vir Biotechnology position peaked at $7.28M in Q1 2021.
204 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2022.

Based on California Public Employees Retirement System's 13F filing for Q1 2022, filed 4 May 2022.